AHMED YOUNES to Female
This is a "connection" page, showing publications AHMED YOUNES has written about Female.
Connection Strength
0.121
-
A Rare Case of Synchronous Oncocytoma and Angiomyolipoma of the Kidney. Am J Case Rep. 2022 Mar 01; 23:e935407.
Score: 0.027
-
Catheter ablation in patients with atrial fibrillation and hypertrophic obstructive cardiomyopathy: a real-world comparative outcomes study. Eur Heart J Qual Care Clin Outcomes. 2026 01 06; 12(1):107-115.
Score: 0.009
-
A Quantitative and Qualitative Assessment of Frozen Section Diagnosis Accuracy and Deferral Rate Across Organ Systems. Am J Clin Pathol. 2022 12 01; 158(6):692-701.
Score: 0.007
-
Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis). Am J Cardiol. 2021 12 15; 161:56-62.
Score: 0.007
-
Sex Differences in Outcomes of Spontaneous Coronary Artery Dissection: Insights From the National Readmissions Database. Cardiovasc Revasc Med. 2022 06; 39:123-124.
Score: 0.007
-
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects. Int J Radiat Oncol Biol Phys. 2021 11 01; 111(3):647-657.
Score: 0.007
-
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. J Immunother Cancer. 2020 10; 8(2).
Score: 0.006
-
Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 09 24; 11(1):4840.
Score: 0.006
-
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity. J Immunother Cancer. 2020 06; 8(1).
Score: 0.006
-
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung Cancer. Cancer Immunol Res. 2020 07; 8(7):883-894.
Score: 0.006
-
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials. J Immunother Cancer. 2020 Jan; 8(1).
Score: 0.006
-
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol. 2019 11 01; 5(11):1597-1604.
Score: 0.006
-
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clin Cancer Res. 2019 12 15; 25(24):7576-7584.
Score: 0.006
-
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer. 2019 09 04; 7(1):237.
Score: 0.006
-
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model. Clin Cancer Res. 2018 11 15; 24(22):5735-5743.
Score: 0.005
-
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol. 2017 02; 12(2):375-382.
Score: 0.005